Finance

Lists
688366:SHA
Haohai Biological
CN¥30.06
-1.83%
(-0.56) 1D
Oct 14, 10:26:29 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688366...
Open
CN¥30.41
High
CN¥30.61
Low
CN¥30.00
Mkt. cap
6.43B
Avg. vol.
434.58K
Volume
130.60K
Dividend
2.83%
Quarterly dividend
CN¥0.21
Ex-dividend date
Sep 4, 2026
P/E ratio
45.61
52-wk high
CN¥52.88
52-wk low
CN¥27.60
EPS
CN¥0.66
No. of employees
2K
Open
CN¥30.41
High
CN¥30.61
Low
CN¥30.00
Mkt. cap
6.43B
Avg. vol.
434.58K
Volume
130.60K
Dividend
2.83%
Quarterly dividend
CN¥0.21
Ex-dividend date
Sep 4, 2026
P/E ratio
45.61
52-wk high
CN¥52.88
52-wk low
CN¥27.60
EPS
CN¥0.66
No. of employees
2K
News stories
From web sources and news partners
About Haohai Biological
CEO-
Employees2K
FoundedJan 24, 2007
Headquarters-
SectorBiotechnology
Website3healthcare.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
606.45M
547.22M
571.44M
607.69M
Cost of goods sold
176.00M
194.43M
192.47M
233.05M
Cost of revenue
176.00M
194.43M
192.47M
233.05M
Research and development expenses
50.70M
48.68M
51.99M
43.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
325.53M
323.79M
247.28M
310.73M
Operating expense
343.99M
407.16M
304.13M
359.52M
Total operating expenses
519.99M
601.59M
496.60M
592.57M
Operating income
86.46M
-54.37M
74.84M
15.12M
Other non operating income
6.89M
107.28M
-3.32M
2.33M
EBT including unusual items
109.87M
-106.26M
96.26M
36.32M
EBT excluding unusual items
104.81M
67.47M
80.49M
22.43M
Income tax expense
17.07M
-20.11M
24.60M
-2.54M
Effective tax rate
15.53%
18.92%
25.56%
-6.99%
Other operating expenses
-33.43M
35.89M
4.04M
6.05M
Net income
93.58M
-53.64M
73.56M
39.07M
Net profit margin
15.43%
-9.80%
12.87%
6.43%
Earnings per share
-
-
-
-
Interest and investment income
18.73M
25.05M
11.27M
12.55M
Interest expense
-2.67M
-10.50M
-2.30M
-2.58M
Net interest expenses
16.06M
14.54M
8.98M
9.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
130.72M
-9.64M
119.57M
62.78M
Gain or loss from assets sale
-
201.00K
-
-1.04M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps